Payment overview · 2025
General Payments
$20.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Leslie M Stuck, MD
Allopathic & Osteopathic Physicians|Internal Medicine · WEST COLUMBIA, SC · NPI 1437110756
Verified facts
What the public records show
CMS Open Payments records show Leslie M Stuck, MD received $20.00 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 58 claims for Farxiga by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $20.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $20.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $20.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
58 | 12 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 708 | 188 |
| Levothyroxine Sodium | Levothyroxine Sodium | 607 | 142 |
| Amlodipine Besylate | Amlodipine Besylate | 463 | 120 |
| Atorvastatin Calcium | Atorvastatin Calcium | 460 | 131 |
| Gabapentin | Gabapentin | 382 | 72 |
| Alprazolam | Alprazolam | 353 | 64 |
| Pantoprazole Sodium | Pantoprazole Sodium | 289 | 83 |
| Valsartan | Valsartan | 280 | 78 |
| Omeprazole | Omeprazole | 277 | 82 |
| Metoprolol Succinate | Metoprolol Succinate | 275 | 76 |
| Sertraline Hcl | Sertraline Hcl | 249 | 56 |
| Metformin Hcl Er | Metformin Hcl | 237 | 63 |
| Ezetimibe | Ezetimibe | 232 | 68 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 230 | 35 |
| Zolpidem Tartrate | Zolpidem Tartrate | 227 | 44 |
| Trazodone Hcl | Trazodone Hcl | 220 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 199 | 58 |
| Losartan Potassium | Losartan Potassium | 181 | 50 |
| Furosemide | Furosemide | 177 | 55 |
| Duloxetine Hcl | Duloxetine Hcl | 173 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 166 | 43 |
| Famotidine | Famotidine | 165 | 49 |
| Meloxicam | Meloxicam | 164 | 44 |
| Ozempic | Semaglutide | 164 | 28 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 156 | 40 |
| Pravastatin Sodium | Pravastatin Sodium | 147 | 39 |
| Lorazepam | Lorazepam | 141 | 40 |
| Carvedilol | Carvedilol | 132 | 37 |
| Montelukast Sodium | Montelukast Sodium | 128 | 41 |
| Tramadol Hcl | Tramadol Hcl | 128 | 36 |
| Bupropion Xl | Bupropion Hcl | 127 | 34 |
| Buspirone Hcl | Buspirone Hcl | 127 | 36 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 117 | 94 |
| Eliquis | Apixaban | 115 | 24 |
| Clonazepam | Clonazepam | 110 | 15 |
| Lisinopril | Lisinopril | 108 | 32 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 107 | 27 |
| Repatha Sureclick | Evolocumab | 104 | 18 |
| Nebivolol Hcl | Nebivolol Hcl | 101 | 29 |
| Pregabalin | Pregabalin | 101 | 16 |
| Metoprolol Tartrate | Metoprolol Tartrate | 98 | 21 |
| Estradiol | Estradiol | 97 | 29 |
| Potassium Chloride | Potassium Chloride | 97 | 33 |
| Methylprednisolone | Methylprednisolone | 96 | 79 |
| Synthroid | Levothyroxine Sodium | 92 | 20 |
| Irbesartan | Irbesartan | 91 | 28 |
| Allopurinol | Allopurinol | 87 | 25 |
| Celecoxib | Celecoxib | 85 | 19 |
| Mounjaro | Tirzepatide | 83 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 82 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 82 | 34 |
| Cephalexin | Cephalexin | 81 | 65 |
| Fluoxetine Hcl | Fluoxetine Hcl | 81 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 76 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 72 | 23 |
| Mirtazapine | Mirtazapine | 71 | 18 |
| Simvastatin | Simvastatin | 68 | 23 |
| Alendronate Sodium | Alendronate Sodium | 67 | 25 |
| Paroxetine Hcl | Paroxetine Hcl | 67 | 11 |
| Valacyclovir | Valacyclovir Hcl | 66 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 65 | 14 |
| Diazepam | Diazepam | 65 | 13 |
| Jardiance | Empagliflozin | 64 | 14 |
| Metformin Hcl | Metformin Hcl | 64 | 19 |
| Myrbetriq | Mirabegron | 64 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 63 | 29 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 62 | 57 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 60 | 20 |
| Atenolol | Atenolol | 59 | 18 |
| Doxepin Hcl | Doxepin Hcl | 59 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 59 | 20 |
| Farxiga | Dapagliflozin Propanediol | 58 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 57 | 13 |
| Prednisone | Prednisone | 56 | 33 |
| Spironolactone | Spironolactone | 54 | 13 |
| Baclofen | Baclofen | 53 | 12 |
| Trulicity | Dulaglutide | 53 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 52 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 52 | 13 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 51 | 12 |
| Fluconazole | Fluconazole | 51 | 33 |
| Premarin | Estrogens, Conjugated | 51 | 11 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 50 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 50 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 49 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 48 | 41 |
| Azithromycin | Azithromycin | 47 | 40 |
| Eszopiclone | Eszopiclone | 46 | 12 |
| Nystatin | Nystatin | 46 | 25 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 46 | 11 |
| Ondansetron Odt | Ondansetron | 46 | 20 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 45 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 45 | suppressed |
| Glipizide Er | Glipizide | 44 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 44 | 34 |
| Azelastine Hcl | Azelastine Hcl | 43 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 42 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 39 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 38 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 37 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 37 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 36 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 36 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 36 | suppressed |
| Chlorthalidone | Chlorthalidone | 35 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 35 | 35 |
| Januvia | Sitagliptin Phosphate | 34 | suppressed |
| Bumetanide | Bumetanide | 33 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 33 | 11 |
| Mupirocin | Mupirocin | 33 | 27 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 33 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 32 | 19 |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 30 | suppressed |
| Ramipril | Ramipril | 30 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 29 | 12 |
| Repaglinide | Repaglinide | 29 | suppressed |
| Temazepam | Temazepam | 29 | suppressed |
| Torsemide | Torsemide | 29 | 11 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 28 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Lansoprazole | Lansoprazole | 27 | suppressed |
| Metronidazole | Metronidazole | 27 | 21 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Gemfibrozil | Gemfibrozil | 26 | suppressed |
| Lactulose | Lactulose | 26 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 25 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 25 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 25 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 24 | suppressed |
| Klor-Con M20 | Potassium Chloride | 24 | suppressed |
| Topiramate | Topiramate | 24 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | 20 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 23 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 22 | 18 |
| Labetalol Hcl | Labetalol Hcl | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 20 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 20 | suppressed |
| Testosterone | Testosterone | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 19 | suppressed |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Naproxen | Naproxen | 19 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 18 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 17 | suppressed |
| Aripiprazole | Aripiprazole | 17 | suppressed |
| Belsomra | Suvorexant | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Yuvafem | Estradiol | 16 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 12 |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Dexamethasone | Dexamethasone | 15 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | 13 |
| Memantine Hcl | Memantine Hcl | 15 | suppressed |
| Mirabegron Er | Mirabegron | 15 | suppressed |
| Ssd | Silver Sulfadiazine | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Carisoprodol | Carisoprodol | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 14 | suppressed |
| Praluent Pen | Alirocumab | 14 | suppressed |
| Progesterone | Progesterone, Micronized | 14 | suppressed |
| Telmisartan | Telmisartan | 14 | suppressed |
| Ajovy Syringe | Fremanezumab-Vfrm | 13 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Finasteride | Finasteride | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 13 | 13 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 12 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 12 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 12 | suppressed |
| Motegrity | Prucalopride Succinate | 12 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 12 | 11 |
| Pitavastatin Calcium | Pitavastatin Calcium | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Qulipta | Atogepant | 11 | suppressed |
| Ramelteon | Ramelteon | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $20.00 · 1 records | AstraZeneca Pharmaceuticals LP | AIRSUPRA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error